[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349938-105":59,"doc-detail-349938-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","epcam-silencing-suppresses-aggressive-phenotypes-and-induces-partial-redifferentiation-in-anaplastic-thyroid-cancer-cells","EpCAM silencing suppresses aggressive phenotypes and induces partial redifferentiation in anaplastic thyroid cancer cells","","Anaplastic thyroid cancer (ATC) is rare yet highly aggressive, with limited survival and incomplete understanding of the molecular drivers of progression. This study examines the function of epithelial cell adhesion molecule (EpCAM) across thyroid cancer cell lines with different differentiation states. EpCAM expression is elevated in ATC cells, and siRNA-mediated EpCAM knockdown suppresses proliferation, adhesion, motility, invasion, and EMT-related signaling while promoting partial redifferentiation. In vivo, EpCAM inhibition reduces lung extravasation, supporting EpCAM as a potential therapeutic target for ATC.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/epcam-silencing-suppresses-aggressive-phenotypes-and-induces-partial-redifferentiation-in-anaplastic-thyroid-cancer-cells/349938/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/epcam-silencing-suppresses-aggressive-phenotypes-and-induces-partial-redifferentiation-in-anaplastic-thyroid-cancer-cells/349938.png","ImageObject",300,407,{"name":92,"@type":93},"Genevieve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the main objective of the study on EpCAM in thyroid cancer cells?","Question",{"text":113,"@type":114},"The study investigated the role of EpCAM in thyroid cancer cell lines with different differentiation status and assessed how EpCAM influences aggressive behaviors and differentiation changes.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does EpCAM expression differ between anaplastic thyroid cancer and differentiated thyroid cancer cells?",{"text":118,"@type":114},"EpCAM expression is significantly elevated in anaplastic thyroid cancer (ATC) cell lines compared with differentiated thyroid cancer (DTC) lines.",{"name":120,"@type":111,"acceptedAnswer":121},"What happens to ATC cells after EpCAM is silenced by siRNA?",{"text":122,"@type":114},"EpCAM knockdown suppresses proliferation, adhesion, motility, and invasion, and it induces differentiation features, including increased thyroid differentiation marker expression and reduced EMT-related markers.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},349938,1790149263,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":36,"preview_page_count":19,"preview_urls":146},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","OPEN ACCESS  \nCitation: Nakamura T, Shibata T, Ito K-i (2026) EpCAM silencing suppresses aggressive phenotypes and induces partial redifferentiation in anaplastic thyroid cancer cells. PLoS One 21(3): e0344276. [https://doi.org/10.1371/](https://doi.org/10.1371/)[ ](https://doi.org/10.1371/)[journal.pone.0344276](journal.pone.0344276)  \nEditor: Tomohito Higashi, Fukushima Medical University, JAPAN  \nReceived: August 3, 2025  \nAccepted: February 18, 2026  \nPublished: March 5, 2026  \nPeer Review History: PLOS recognizes the benefits of transparency in the peer review process; therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. The editorial history of this article is available here: [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pone.0344276  \nCopyright: © 2026 Nakamura et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  \nRESEARCH ARTICLE  \nEpCAM silencing suppresses aggressive phenotypes and induces partial redifferentiation in anaplastic thyroid cancer cells  \nTeruo Nakamura☯, Tomohiro Shibata☯, Ken-ichi Ito*  \nDivision of Breast and Endocrine Surgery, Department of Surgery, Shinshu University School of Medicine, Asahi, Matsumoto, Japan  \n☯ N.T. and S.T. contributed equally to this work.  \n* [kenito@shinshu-u.ac.jp](kenito@shinshu-u.ac.jp)  \nAbstract  \nAnaplastic thyroid cancer (ATC) is a rare but highly aggressive malignancy with a dismal prognosis. Although recent advances in targeted therapies have modestly improved survival, the molecular mechanisms driving ATC progression remain incompletely elucidated. Epithelial cell adhesion molecule (EpCAM), a multifunctional cell-surface protein, is implicated in proliferation, migration, and stemness in various cancers. However, its role in thyroid cancer progression remains unclear. In this study, we investigated the function of EpCAM in thyroid cancer cell lines of varying differentiation status. EpCAM expression was significantly elevated in ATC cell lines compared with differentiated thyroid cancer (DTC) lines. EpCAM knockdown by siRNA suppressed proliferation, adhesion, motility, and invasion in ATC cells, but had minimal effects on DTC cells. Morphological analyses revealed that EpCAM silencing induced differentiation features, including follicle-like structure formation and increased expression of thyroid differentiation markers such as thyroglobulin and PAX8 inATC cells. Furthermore, EpCAM inhibition decreased mesenchymal marker expression, reduced filopodia formation, and suppressed extravasation of cancer cells into the lung in an in vivo mouse model. Mechanistically, EpCAM knockdown attenuated epithelial–mesenchymal transition (EMT)-related pathways but did not affect major proliferation signaling cascades in ATC cells. These findings suggest that EpCAM promotes dedifferentiation and metastatic potential in ATC through EMT modulation. Our results provide new insights into the role of EpCAM in thyroid cancer biology and highlight its potential as a therapeutic target in ATC. Further studies are warranted to elucidate the mechanisms linking EpCAM to anaplastic transformation and to explore the therapeutic efficacy of EpCAM-targeting strategies in aggressive thyroid cancers.  \nPLOS One | [https://doi.org/10.1371/journal.pone.0344276](https://doi.org/10.1371/journal.pone.0344276) March 5, 2026 1 / 16  \nand reproduction in any medium, provided the original author and source are credited.  \nData availability statement: All relevant data are within the manuscript and its Supporting  Information files.  \nFunding: This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science. KI:\\#20K08953 TS:\\#20J00393 and \\#21K06641 .  \nCompeting interests: The authors have declared that no competing interests exist.  \nTN is currently an","cbCaijLdog1LkGYX","https://ap.wps.com/l/cbCaijLdog1LkGYX","pdf",2032906,16,"English","# Abstract\n## EpCAM role in ATC across differentiation states\n## Effects of EpCAM knockdown on malignant phenotypes\n## Mechanistic links to EMT-related pathways\n## In vivo impact on metastatic behavior","[{\"question\":\"What was the main objective of the study on EpCAM in thyroid cancer cells?\",\"answer\":\"The study investigated the role of EpCAM in thyroid cancer cell lines with different differentiation status and assessed how EpCAM influences aggressive behaviors and differentiation changes.\"},{\"question\":\"How does EpCAM expression differ between anaplastic thyroid cancer and differentiated thyroid cancer cells?\",\"answer\":\"EpCAM expression is significantly elevated in anaplastic thyroid cancer (ATC) cell lines compared with differentiated thyroid cancer (DTC) lines.\"},{\"question\":\"What happens to ATC cells after EpCAM is silenced by siRNA?\",\"answer\":\"EpCAM knockdown suppresses proliferation, adhesion, motility, and invasion, and it induces differentiation features, including increased thyroid differentiation marker expression and reduced EMT-related markers.\"}]","EpCAM silencing suppresses aggressive phenotypes and induces partial redifferentiation in anaplastic thyroid cancer cells | PDF",1790086345,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/41c5edaec44ff6133344f4f7e9cc3a73.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/be2aeeba34a9440f9549bcbaab171502.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a219899783398dc68e13d8a17306ecca.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/720a93b69baa84996ed3c76dd5088622.webp",980,1268]